AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas

A Rationally Designed Histone Deacetylase Inhibitor with Distinct Antitumor Activity against Ovarian Cancer

(2015) Ya-Ting Yang et al.   NEOPLASIA

AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit

(2010) T.-Y. Lin et al.   BLOOD

Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism

(2010) Mahlon D. Johnson et al.   JOURNAL OF NEURO-ONCOLOGY

Epidemiology and etiology of meningioma

(2010) Joseph Wiemels et al.   JOURNAL OF NEURO-ONCOLOGY

ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma

(2010) S. Ammoun et al.   NEURO-ONCOLOGY

Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients

(2010) Scott R. Plotkin et al.   OTOLOGY & NEUROTOLOGY

The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo

(2010) David M. Lucas et al.   PLoS One

Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2

(2009) D. G. Evans et al.   CLINICAL CANCER RESEARCH

Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells

(2009) Tina X. Lee et al.   EUROPEAN JOURNAL OF CANCER

Activation of ERK, AKT and JNK signalling pathways in human schwannomasin situ

(2009) David A Hilton et al.   HISTOPATHOLOGY

HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity

(2009) Vivek Sharma et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Effect of tumor removal on tinnitus in patients with vestibular schwannoma

(2009) Katsuharu Kameda et al.   JOURNAL OF NEUROSURGERY

Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2

(2009) Scott R. Plotkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neurofibromatosis type 2 (NF2): A clinical and molecular review

(2009) D Gareth R Evans   Orphanet Journal of Rare Diseases

Phosphatidylinositol 3-Kinase/AKT Pathway Activation in Human Vestibular Schwannoma

(2009) Abraham Jacob et al.   OTOLOGY & NEUROTOLOGY

Merlin and the ERM proteins – regulators of receptor distribution and signaling at the cell cortex

(2009) Andrea I. McClatchey et al.   TRENDS IN CELL BIOLOGY

OSU-HDAC42, a Histone Deacetylase Inhibitor, Blocks Prostate Tumor Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model

(2008) A. M. Sargeant et al.   CANCER RESEARCH

Role of platelet-derived growth factors in physiology and medicine

(2008) J. Andrae et al.   GENES & DEVELOPMENT

Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas

(2008) Mahlon D. Johnson et al.   JOURNAL OF NEURO-ONCOLOGY